COLL vs DRI · P/E 17, rev $181.9M vs P/E 22, rev $12.08B
Collegium Pharmaceutical Inc (COLL) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the COLL and DRI stock pages for the full models.
Not investment advice.